New Member Grant Opportunity! Announcing CPP’s 2nd Dose Program

Getting patients back in to your practice for follow-up shots is a challenge for most practices across the country, as evidenced by the following statistics:

Stats Table

CPP has launched the 2nd Dose Program, providing an opportunity for members to examine your practice’s 2nd dose immunization rates for meningococcal ACWY, meningococcal B, HPV, and/or adult pneumococcal, and earn an educational grant!  It is as easy as 1, 2, 3…

For information on how to participate, please contact the CPP office at or 877-277-9330.




Merck Vaccine Supply Interruptions

Last month, we sent information about some supply interruptions announced by Merck. Please see below for updates to the supply issues, which now include a pediatric vaccine:

  • Adult formulation of Vaqta, a hepatitis A vaccineanticipated return: Q3 2017
  • Adult formulation of RecombivaxHB, a hepatitis B vaccine – anticipated return: Q3 2018
  • Pediatric formulation of RecombivaxHB, a hepatitis B vaccine – anticipated return: Q1-Q2 2018

We understand that some wholesalers may have inventory on hand of pediatric RecombivaxHB; please consider reaching out to your supplier to inquire about availability.


Please note that these interruptions do not impact the supply of the pediatric formulation of Vaqta at this time.

During product shortages, CPP does not enforce program purchase requirements for the affected vaccines.  To stay up to date on product availability, refer to the Merck Vaccines Supply Status website.